Catalyst Wire Dossier Catalyst Wire Dossier

tiotropium bromide inhalation solution

tiotropium bromide inhalation solution · Nephron Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for tiotropium bromide inhalation solution, covering 2021-05-10 to 2021-05-10. Get the full timeline:

Most recent: Clinical Trial Update: Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease [Phase 2]

See pricing